613 related articles for article (PubMed ID: 18418278)
1. Prognostic impact of primary tumor volume in patients with nasopharyngeal carcinoma treated by definitive radiation therapy.
Shen C; Lu JJ; Gu Y; Zhu G; Hu C; He S
Laryngoscope; 2008 Jul; 118(7):1206-10. PubMed ID: 18418278
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
3. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
4. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control.
Sze WM; Lee AW; Yau TK; Yeung RM; Lau KY; Leung SK; Hung AW; Lee MC; Chappell R; Chan K
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):21-7. PubMed ID: 15093895
[TBL] [Abstract][Full Text] [Related]
5. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis.
Chua DT; Sham JS; Kwong DL; Choy DT; Au GK; Wu PM
Cancer; 1996 Jul; 78(2):202-10. PubMed ID: 8673993
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
[TBL] [Abstract][Full Text] [Related]
9. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma.
Lu JJ; Kong L; Shakespeare TP; Loh KS; Zhang Q; Tan KS; Lee KM
Oral Oncol; 2008 Jul; 44(7):703-9. PubMed ID: 18061528
[TBL] [Abstract][Full Text] [Related]
10. [Intensity modulated radiation therapy for 49 patients with recurrent nasopharyngeal carcinoma].
Lu TX; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Zeng ZF; Huang SM; Lin CG; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):386-9. PubMed ID: 12921573
[TBL] [Abstract][Full Text] [Related]
11. Nasopharyngeal carcinoma with cranial nerve palsy: the importance of MRI for radiotherapy.
Chang JT; Lin CY; Chen TM; Kang CJ; Ng SH; Chen IH; Wang HM; Cheng AJ; Liao CT
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1354-60. PubMed ID: 16297716
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series.
Lin S; Pan J; Han L; Zhang X; Liao X; Lu JJ
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1071-8. PubMed ID: 19362784
[TBL] [Abstract][Full Text] [Related]
13. Sequential external beam radiotherapy and high-dose-rate intracavitary brachytherapy in T1 and T2 nasopharyngeal carcinoma: an evaluation of long-term outcome.
Thiagarajan A; Lin K; Tiong CE; Tan LK; Loh TK; Goh BC; Lu JJ
Laryngoscope; 2006 Jun; 116(6):938-43. PubMed ID: 16735885
[TBL] [Abstract][Full Text] [Related]
14. [Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer].
Xie CY; Wu SX; Jin XC; Yu JY; Wang JH; Li WF; Zhang P
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2412-5. PubMed ID: 18036320
[TBL] [Abstract][Full Text] [Related]
15. Survival outcome of patients with nasopharyngeal carcinoma with first local failure: a study by the Hong Kong Nasopharyngeal Carcinoma Study Group.
Yu KH; Leung SF; Tung SY; Zee B; Chua DT; Sze WM; Law SC; Kam MK; Leung TW; Sham JS; Lee AW; Au JS; Hui EP; Sze WK; Cheng AC; Yau TK; Ngan RK; Wong FC; Au GK; Chan AT;
Head Neck; 2005 May; 27(5):397-405. PubMed ID: 15726589
[TBL] [Abstract][Full Text] [Related]
16. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
[TBL] [Abstract][Full Text] [Related]
17. [Primary radiotherapy of nasopharyngeal carcinoma].
Rübe C; Grevers G; Grimminger H; Wendt T; Rohloff R
Laryngorhinootologie; 1995 Feb; 74(2):103-7. PubMed ID: 7710601
[TBL] [Abstract][Full Text] [Related]
18. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for recurrence and survival rate.
Chu ST; Wu PH; Chou P; Lee CC
Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S115-20. PubMed ID: 18236065
[TBL] [Abstract][Full Text] [Related]
19. Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.
Lu JJ; Shakespeare TP; Thiagarajan A; Zhang X; Liang L; Tan S
Laryngoscope; 2005 May; 115(5):806-10. PubMed ID: 15867644
[TBL] [Abstract][Full Text] [Related]
20. Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.
Yeh SA; Huang YJ
Am J Clin Oncol; 2007 Aug; 30(4):401-5. PubMed ID: 17762441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
